Specifically, thiazides are believed to upregulate AQP2 in the collecting duct, without the involvement of vasopressin, either directly or through the prostaglandin E2 pathway, consistent with drug-induced NSIAD [14,45]. Here, AQP2 is linked to nephrogenic syndrome of inappropriate antidiuresis.